Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Maximizing the value of the open label extension phase of randomized ...
Open Label Randomized Controlled Trial Saniona Initiates Phase 2b
(PDF) An open label phase II study of safety and clinical activity of ...
(PDF) A phase 2 single center open label randomised control trial for ...
Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide ...
1325 SCOPE, an open label phase 2 parallel multi cohort clinical trial ...
38 what is an open label study
(PDF) A Randomized Open label Phase-II Clinical Trial with or without ...
(PDF) A 12 Week, Open Label, Phase I/IIa Study Using Apatone for the ...
HYDRA study design: two parallel, noncomparative, open label phase-I ...
A phase I, open label, clinical study to assess the safety and ...
Trial design of single arm, open-label phase III E4 FREEDOM trials in ...
A Phase I, Open-Label, Dose Confirmation, Escalation, and Expansion ...
Open-Label Phase 1/2 Study of Daratumumab-Based Desensitization Before ...
Trial designs. a Note: Results from the open-label phase of Study 1 are ...
Patient disposition. a Open-label phase included an 8-week run-in phase ...
(PDF) Phase II OpenLabel Trial of Intranasal Ketamine for depression
Design of open-label, phase 1 clinical drug-drug interaction PK study ...
A Phase 1, Open-Label, Multicenter, Dose Escalation Study of PRT2527, a ...
Design of the multicenter, open-label, phase 1/2 safety and ...
A phase I open-label study to investigate safety and tolerability ...
(PDF) A randomized, open-label, Phase III study of obinutuzumab or ...
Study design for the open-label phase and double-blind reversal phase ...
Interim Analysis from the Ongoing Open-Label Phase III
Study design: open-label, nonblinded, multicenter, Phase II trial ...
(PDF) Multicenter Randomized Open-Label Phase II Clinical Study ...
(PDF) An Open-Label Phase II Trial NCT03812393 to Evaluate the Efficacy ...
(PDF) Open‐label, Phase 2 study of roxadustat for the treatment of ...
(PDF) An Open‐Label, Phase 1 Study to Assess the Effects of Hepatic ...
(PDF) A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent ...
(PDF) An Open-Label, Phase II Study of the Safety of Pirfenidone in ...
(PDF) Randomized, open-label, phase 2 study of andecaliximab plus ...
CONSORT flowchart for A single-arm, open-label, phase 2 clinical trial ...
CONSORT flowchart for a single-arm, open-label, phase II clinical trial ...
Design and Rationale for a Phase II, Randomized, Open-Label, Two-Cohort ...
A phase 1b open-label study to evaluate the safety, tolerability ...
(PDF) Open-label, Phase II Study to Assess Efficacy and Safety of ...
Prospective, Randomized, Open-Label Phase II Trial on Concomitant ...
(PDF) Open-label, phase II study of routine high-flow nasal oxygen ...
Study design for the open‐label, lead‐in phase of the ongoing ...
(PDF) A Multicenter, Open-Label, Phase I/II Study of FN-1501 in ...
(PDF) Results from Part 1 Safety Run-in Period of a 2-part, Phase 2 ...
(PDF) Multicenter, Randomized, Open-Label, Phase III Trial of ...
Seizure occurrences during the open-label phase with all patients with ...
(PDF) Open-Label Phase II Study Evaluating the Efficacy and Safety of ...
(PDF) A first-in-human, open-label Phase 1b and a randomised, double ...
(PDF) Randomized, open-label phase II study of brigatinib and ...
(PDF) A randomized and open-label phase II trial reports the efficacy ...
POS0046 PRELIMINARY RESULTS OF AN OPEN-LABEL, MULTICENTRE, PHASE 1/2 ...
(PDF) A multicenter, randomized, open‐label, phase 2 clinical study of ...
(PDF) The Pharmacokinetic Profile of Palovarotene: An Open-Label Phase ...
Completed Open-Label, Phase 2/3 Uncontrolled Clinical Trials of ...
An open-label, randomized phase III trial of gemcitabine and ...
Treatment failures during the open-label phase | Download Scientific ...
AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO ...
Single-arm, open-label phase 2 trial of pembrolizumab in patients with ...
(PDF) An open-label, phase IV randomised controlled trial of two ...
COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of ...
Trial design of the open-label phase I/II CodeBreaK 100 trial in adults ...
(PDF) Phase 2 Open-Label Trial Investigating Percutaneous Laser ...
A Phase 1, Open-Label, Dose-Escalation Study of PRT1419, a Selective ...
(PDF) An open-label Phase I/II clinical trial of pyrimethamine for the ...
(PDF) An open-label phase I dose-finding study of APR-246 in ...
An open-label, phase IB/II study of abemaciclib with paclitaxel for ...
Completed Open-Label, Phase 3 Exploratory Clinical Trials of ...
Design of an open-label randomized phase II trial examining the effect ...
An open-label, phase I/II trial to determine the maximum tolerated dose ...
(PDF) A phase I, open-label, multicenter study to evaluate the ...
(PDF) Phase 1/1b open-label, dose-escalation study of fruquintinib in ...
(PDF) Randomized, Open-Label Phase II Study Evaluating the Efficacy and ...
PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX ...
(PDF) CATALYST trial protocol: A multicentre, open-label, phase II ...
A schematic of a typical randomised clinical trial. A typical ...
Accenture Life Sciences - ppt download
PPT - Challenging Cases in Cancer: Advanced Breast Cancer PowerPoint ...
Sotorasib versus docetaxel for previously treated non-small-cell lung ...
Results of Open-label Extension of the ORIGIN Study - Explore the ...
Combination lurbinectedin and doxorubicin versus physician's choice of ...
Frontiers | A first-in-human, open-label, dose-escalation and dose ...
Open-label extension (OLE) study design. a Patients who received the ...
Figure 1 from Cemiplimab in locally advanced cutaneous squamous cell ...
(PDF) Efficacy and safety of camrelizumab plus apatinib during the ...
Open‐label extension study design. Patients were permitted to switch ...
Ipilimumab combined with stereotactic radiosurgery in melanoma patients ...
(PDF) Burosumab versus conventional therapy in children with X-linked ...
Gedatolisib in combination with palbociclib and endocrine therapy in ...
(PDF) A multicentre, open-label, phase-I/randomised phase-II study to ...
Pembrolizumab with or without bevacizumab in platinum-resistant ...
(PDF) (Open label) placebo effects on sleep quality, sleep duration ...
Presenters Biff F. Palmer, MD Robert Toto, MD - ppt download
Nivolumab plus ipilimumab versus nivolumab in microsatellite ...
Schematic diagram of the design of an international open-label ...
(PDF) A two-arm, randomized, controlled, multi-centric, open-label ...
Open-Label Clinical Trial Strategies- BioPharma Services
Frontiers | Targeted therapy for intractable cancer on the basis of ...
(PDF) Bruton’s tyrosine kinase inhibition for the prevention of ...
(PDF) Efficacy and Safety of COVID-19 Convalescent Plasma in ...
A, Quality assessment tool for nonrandomized, uncontrolled, open-label ...
The study was design as single-arm open-label trial consisting of a 14 ...
(PDF) Efficacy and safety of sofosbuvir in the treatment of SARS-CoV-2 ...
J013 ANX005-HD-01b: clinical progression in patients in Enroll-HD prior ...
Clinical assessment in the double-blind randomized placebo-controlled ...
(PDF) Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in ...
Understanding Open-Label Trials: A Guide for English Language Learners ...
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia ...
Primary disposition of patients (open-label phase). EULAR: European ...
Open-Label Study - Clinical Research Explained | VIARES
02848-4%2Fasset%2F4a2cd465-a6af-4b86-a08d-fbaad458c46a%2Fmain.assets%2Fgr2.jpg&w=3840&q=75)
